Chinese FDA Released Guidelines for Rx-OTC Switch

more+
less-
more+
less-

The State Food and Drug Administration (“SFDA”) recently announced a set of technical guidelines for switching prescription drugs to over-the-counter drugs (“Rx-OTC Switch Guidelines”). The Rx-OTC Switch Guidelines include the Tentative Evaluation Guidelines for Rx-OTC Switch, the Principles for Defining the Indications of OTC Drugs, the Evaluation Guidelines for Traditional Chinese Medicines (“TCM”) with Toxic Ingredients to be switched to OTC Drugs, the Principles for Defining Class B OTC Drugs, the Indications of OTC Drugs (TCM Section), and the Indications of OTC Drugs (Chemical Drugs Section).

A prescription drug is qualified for OTC evaluation if it meets the following basic requirements...

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ropes & Gray LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×